North America Cell Line Development Market to 2027 - Regional Analysis and Forecasts by Type (Primary Cell Line, Hybridomas, Continuous Cell Lines, and Recombinant Cell Line); By Product (Equipment and Media & Reagent); Application (Drug Discovery, Bioproduction and Tissue Engineering); and Geography


The North America cell line development market is expected to reach US$ 3,829.46 Mn in 2027 from US$ 1,393.32 Mn in 2018. The market is estimated to grow with a CAGR of 13.5% from 2020-2027.
The growth in North America is characterized by an increase in the demand for innovative products from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes. Moreover, increasing focus on advanced method incorporation in healthcare, government, and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research are further expected to stimulate growth and contribute to exceptional revenue generation for the cell line development market in North America. The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. The Biotech Startup Revolution has also assisted in promoting the new ventures holding promising and innovative ideas in the country and supported in maximizing the revenue generation and thus the economic position of North America in the global cell line development market.
Moreover, the companies are performing various activities for the cell line development market, for instance, Selexis, Carestream Avacta, JSR Life Sciences has done recent developments for products. 
In 2019, the recombinant cell line segment held the most significant market share of the cell line development market, by type. This segment is also anticipated to dominate the market in 2027 owing to its popularity among manufacturers for the production of therapeutic recombinant proteins. The hybridomas segment is anticipated to witness growth at a significant rate during the forecast period.
The US cell line development market is dominated by intraoral media and reagent segment in 2019 with a considerable market share, by product. This segment is also predicted to dominate the market in 2027. Also, media and reagent segment is anticipated to witness growth at a significant rate during the forecast period, 2020 to 2027, owing to the increasing research activities in biotechnology sector.
In 2019, the bioproduction segment held a considerable market share of the cell line development market, by the application. This segment is also predicted to dominate the market in 2027 owing to higher demand of biologics. However, the drug discovery segment is anticipated to witness growth at a significant rate during the forecast period.
Some of the major primary and secondary sources for cell line development included in the report are American Society of Clinical Oncology, American Type Culture Collection, California Institute for Regenerative Medicine, and others.
TABLE OF CONTENTS
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. North America Cell Line Development Market –  Key Takeaways
3. North America Cell Line Development Market –  Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Cell Line Development Market – By Type
3.2.2 North America Cell Line Development Market – By Product
3.2.3 North America Cell Line Development Market – By Application
3.2.4 North America Cell Line Development Market – By Country
3.3 PEST Analysis
3.3.1 North America – PEST Analysis
4. North America Cell Line Development Market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Research and Development Activities
4.1.2 Rising Incidence of Chronic Diseases
4.2 Key Market Restraints
4.2.1 Risk Associated with Cell Line Contamination
4.3 Key Market Opportunities
4.3.1 The Rise in Production of Biosimilars
4.4 Future Trends
4.4.1 Increasing Approvals of Gene/Cell Therapies
4.5 Impact Analysis
5. Cell Line Development Market – North America Analysis
5.1 North America Cell Line Development Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.3.1 Merck KGaA
5.3.2 Thermo Fisher Scientific Inc.
5.4 Expert Opinions
6. North America Cell Line Development Market Analysis – By Type
6.1 Overview
6.2 North America Cell Line Development Market, By Type, 2018 & 2027 (%)
6.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
6.4 Recombinant Cell Line Market
6.4.1 Overview
6.4.2 North America Recombinant Cell Line Market Revenue And Forecasts To 2027(US$ Mn)
6.5 Hybridomas
6.5.1 Overview
6.5.2 North America Hybridoma Market Revenue And Forecasts To 2027 (US$ Mn)
6.6 Primary Cell Line
6.6.1 Overview
6.6.2 North America Primary Cell Line Market Revenue and Forecasts to 2027 (US$ Mn)
6.7 Continuous Cell Lines
6.7.1 Overview
6.7.2 North America Continuous Cell Lines Market Revenue and Forecasts to 2027 (US$ Mn)
7. North America Cell Line Development Market Analysis – By Product
7.1 Overview
7.2 North America Cell Line Development Market, By Product, 2018 & 2027 (%)
7.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)
7.4 Media And Reagent Market
7.4.1 Overview
7.4.2 North America Media and Reagent Market Revenue And Forecasts To 2027(US$ Mn)
7.5 Equipment
7.5.1 Overview
7.5.2 North America Equipment Market Revenue And Forecasts To 2027 (US$ Mn)
8. North America Cell Line Development Market Analysis – By Application
8.1 Overview
8.2 North America Cell Line Development Market, By Application, 2018 & 2027 (%)
8.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
8.4 Bioproduction
8.4.1 Overview
8.4.2 North America Bioproduction Market Revenue And Forecasts To 2027(US$ Mn)
8.5 Drug Discovery
8.5.1 Overview
8.5.2 North America Drug Discovery Market Revenue And Forecasts To 2027 (US$ Mn)
8.6 Tissue Engineering
8.6.1 Overview
8.6.2 North America Tissue Engineering Market Revenue And Forecasts To 2027 (US$ Mn)
9. North America Cell Line Development Market Revenue And Forecasts To 2027
9.1 Overview
9.2 North America Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.3 North America Cell Line Development Market Revenue And Forecasts To 2027, By Type (US$ Mn)
9.4 North America Cell Line Development Market Revenue And Forecasts To 2027, By Product (US$ Mn)
9.5 North America Cell Line Development Market Revenue And Forecasts To 2027, By Application (US$ Mn)
9.6 North America Cell Line Development Market Revenue And Forecasts To 2027, By Country (%)
9.7 US Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.7.1 US Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.7.2 US Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.7.3 US Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.7.4 US Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.8 Canada Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.8.1 Canada Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.8.2 Canada Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.8.3 Canada Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.8.4 Canada Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.9 Mexico Cell Line Development Market Revenue And Forecasts To 2027 (US$ Mn)
9.9.1 Mexico Cell Line Development Market Revenue and Forecasts to 2027 (US$ Mn)
9.9.2 Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.9.3 Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.9.4 Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn)
10. Cell Line Development Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in The Cell Line Development Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies in the Cell Line Development Market, 2016-2019
10.3.3 Expansion
10.3.3.1 Recent Expansion By Players In The Cell Line Development Market
10.3.4 Inorganic developments
10.3.5 Overview
10.3.6 Inorganic Growth Strategies In The Cell Line Development Market, 2016-2019
10.3.7 Agreements
10.3.7.1 The Cell Line Development Market, By Agreements
10.3.8 Acquisitions
10.3.8.1 Acquisitions By Players In The Cell Line Development Market
11. Cell Line Development Market–Key Company Profiles
11.1 Merck KGaA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Information
11.2.4 Product /Services Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sartorius AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Selexis
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product/Service Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Biofactura, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Wuxi AppTec
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Service Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 LakePharma, Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 General Electric
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Lonza
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Information
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Corning Incorporated
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research

LIST OF TABLES Table 1. North America Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn) Table 2. North America Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn) Table 3. North America Cell Line Development Market Revenue And Forecasts to 2027, By Applicayion (US$ Mn) Table 4. North America Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn) Table 5. North America Cell Line Development Market Revenue And Forecasts to 2027, By product (US$ Mn) Table 6. North America Cell Line Development Market Revenue And Forecasts to 2027, By application (US$ Mn) Table 7. US Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn) Table 8. US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn) Table 9. US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn) Table 10. Canada Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn) Table 11. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn) Table 12. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn) Table 13. Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Type (US$ Mn) Table 14. Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Product (US$ Mn) Table 15. Mexico Cell Line Development Market Revenue And Forecasts to 2027, By Application (US$ Mn) Table 16. Recent Expansion in the Cell Line Development Market Table 17. The Cell Line Development Market by Agreements Table 18. Acquisitions in the Cell Line Development Market Table 19. Glossary of Terms, Cell Line Development Market

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Biotechnology Reports

Global Pyrogen Testing Market Size study, by Application (Pharmaceuticals and Biologicals Manufacturing, Medicals Devices Manufacturing, Other Applications) By Product (Kits and Reagents, Services, Instruments) By TEST (LAL Test, In Vitro Pyrogen Test, Rabbit Test) and Regional Forecasts 2019-2026

Global Pyrogen Testing Market is valued approximately USD 758.4 million in 2018 and is anticipated to grow with a healthy growth rate of more than 11.50% over the forecast period 2019-2026. Pyrogen testing is a procedure that defines the existence of...

Global Microscopy Market Size study, by Product (Microscopes, Software, Accessories), by Type (Optical Microscopes, Electron Microscopes, Scanning Probe Microscopes, Others), by Application (Semiconductors, Lifesciences, Material Science, Others), by End-User (Industries, Academic & Research Institutes) and Regional Forecasts 2019-2026

Global Microscopy Market is valued approximately at USD 5.92 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.50% over the forecast period 2019-2026. A microscopy have three well-recognized branches of microscopy t...

Global Industrial Agitator Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

According to HJ Research's study, the global Industrial Agitator market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Industr...

Global Industrial UPS Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

According to HJ Research's study, the global Industrial UPS market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Industrial U...

Global Eddy Current Testing Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

According to HJ Research's study, the global Eddy Current Testing market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Eddy C...

Other Reports by The Insight Partners

North America E-Invoicing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Cloud, On-Premise); End-User (B2B, B2C, Others)

The North America e-Invoicing market was valued at US$ 890.1 million in 2019 and is projected to reach US$ 2,776.3 million by 2027; it is expected to grow at a CAGR of 15.8% from 2020 to 2027. Millions of invoices are generated across the globe on ...

Europe E-Invoicing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Cloud, On-Premise); End-User (B2B, B2C, Others)

The e-Invoicing market in Europe was valued at US$ 1,241.7 million in 2019 and is projected to reach US$ 4,217.6 million by 2027; it is expected to grow at a CAGR of 17.1% from 2020 to 2027. In Europe, the adoption of electronic and digital processes...

Asia Pacific E-Invoicing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Cloud, On-Premise); End-User (B2B, B2C, Others)

The e-Invoicing market in Asia-Pacific was valued at US$ 1,019.8 million in 2019 and is projected to reach US$ 4,075.8 million by 2027; it is expected to grow at a CAGR of 19.4% from 2020 to 2027. The adoption of electronic and digital processes/solu...

North America Nano PLC Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Component (Hardware and Software); Type (Fixed Nano PLC and Modular Nano PLC); Industry (Automotive, Energy & Power, Home & Building Automation, Oil & Gas, Pharmaceutical, Metals and Mining, and Others)

The Nano PLC market in North America was valued at US$ 890.1 million in 2019 and is projected to reach US$ 2,776.3 million by 2027; it is expected to grow at a CAGR of 15.8% from 2020 to 2027. The growth of the market in North America is attributed t...

Europe Nano PLC Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Component (Hardware and Software); Type (Fixed Nano PLC and Modular Nano PLC); Industry (Automotive, Energy & Power, Home & Building Automation, Oil & Gas, Pharmaceutical, Metals and Mining, and Others)

The Nano PLC market in Europe was valued at US$ 863.6 million in 2019 and is projected to reach US$ 1,231.2 million by 2027; it is expected to grow at a CAGR of 4.6% from 2020 to 2027. Digital transformation is a major factor in boosting the European...

Publisher: The Insight Partners
Chat with us